华东医药

- 000963

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
华东医药(000963) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入3,266,414.312,167,492.901,073,578.794,190,570.743,147,765.48
营业收入3,266,414.312,167,492.901,073,578.794,190,570.743,147,765.48
二、营业总成本2,928,959.821,941,841.98962,000.713,749,302.022,828,881.17
营业成本2,171,568.951,432,739.61720,659.812,798,854.722,123,180.34
营业税金及附加17,298.1911,458.525,726.5225,063.8816,379.20
销售费用479,198.03322,904.42147,075.35640,852.21472,751.25
管理费用109,002.8072,529.6135,539.54139,738.82117,902.32
财务费用1,132.762,242.421,461.802,226.473,801.78
研发费用150,759.0899,967.4051,537.69142,565.9294,866.29
资产减值损失----------
公允价值变动收益----------
投资收益-11,936.81-6,726.58-4,262.41-12,919.07-8,671.03
其中:对联营企业和合营企业的投资收益-7,525.14-3,536.58-2,824.95-6,845.31-5,456.30
汇兑收益----------
三、营业利润335,059.02224,337.37113,225.73432,473.73321,535.22
加:营业外收入563.92415.7676.918,800.93744.27
减:营业外支出9,360.785,436.792,807.5411,123.278,891.13
其中:非流动资产处置损失----------
四、利润总额326,262.16219,316.34110,495.09430,151.39313,388.36
减:所得税费用52,076.3338,983.4319,096.6880,732.8257,127.93
五、净利润274,185.83180,332.9091,398.42349,418.56256,260.43
归属于母公司所有者的净利润274,791.60181,482.6991,470.85351,210.47256,232.67
少数股东损益-605.78-1,149.79-72.43-1,791.9027.76
六、每股收益
基本每股收益(元/股)1.56821.02930.52242.00461.4644
稀释每股收益(元/股)1.56661.03460.52132.00341.4639
七、其他综合收益8,336.162,375.618,204.50-1,025.671,767.59
八、综合收益总额282,521.99182,708.5199,602.92348,392.90258,028.02
归属于母公司所有者的综合收益总额283,127.77183,858.3099,675.35350,184.80258,000.26
归属于少数股东的综合收益总额-605.78-1,149.79-72.43-1,791.9027.76
下载全部历史数据到excel中 返回页顶